Genetic Technologies Limited
GNTLF · OTC
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Revenue | $414 | $4,800 | $3,959 | $4,532 |
| % Growth | -91.4% | 21.2% | -12.7% | – |
| Cost of Goods Sold | $0 | $2,004 | $5,940 | $5,756 |
| Gross Profit | $414 | $2,796 | -$1,981 | -$1,223 |
| % Margin | 100% | 58.3% | -50% | -27% |
| R&D Expenses | $0 | $363 | $390 | $723 |
| G&A Expenses | $281 | $9,480 | $336 | $570 |
| SG&A Expenses | $1,219 | $5,903 | $1,800 | $3,649 |
| Sales & Mktg Exp. | $938 | $1,355 | $1,463 | $1,297 |
| Other Operating Expenses | $0 | $0 | -$390 | -$1,013 |
| Operating Expenses | $1,219 | $6,266 | $1,800 | $3,359 |
| Operating Income | -$805 | -$3,470 | -$5,163 | -$4,583 |
| % Margin | -194.6% | -72.3% | -130.4% | -101.1% |
| Other Income/Exp. Net | -$2,248 | -$2,128 | -$1,256 | -$1,718 |
| Pre-Tax Income | -$3,053 | -$5,598 | -$6,419 | -$6,301 |
| Tax Expense | $0 | $0 | $0 | -$10 |
| Net Income | -$4,087 | -$5,598 | -$6,419 | -$6,291 |
| % Margin | -987.2% | -116.6% | -162.2% | -138.8% |
| EPS | -0.021 | -0.038 | -0.053 | -0.065 |
| % Growth | 43.6% | 29.2% | 18.4% | – |
| EPS Diluted | -0.021 | -0.038 | -0.053 | -0.065 |
| Weighted Avg Shares Out | 193,120 | 149,020 | 120,785 | 96,635 |
| Weighted Avg Shares Out Dil | 144,269 | 149,017 | 120,785 | 96,635 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $30 | $90 | $140 |
| Interest Expense | $24 | $39 | $13 | $14 |
| Depreciation & Amortization | $64 | $254 | $155 | $346 |
| EBITDA | -$1,331 | -$5,305 | -$2,044 | -$5,941 |
| % Margin | -321.6% | -110.5% | -51.6% | -131.1% |